Previous 10 | Next 10 |
(NewsDirect) Radiopharm Theranostics Ltd (ASX:RAD) CEO and managing director Riccardo Canevari tells Proactive the company has begun the initiation process for entry into the Nasdaq stock exchange under the ticker RADX, gaining a second listing in the US capital market. RAD’s recently ...
Proposed listing on NASDAQ with RADX ticker symbol Form 20-F registration filed with Securities and Exchange Commission Trading expected to commence late March 2023 SYDNEY, Australia, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Radiopharm Theranostics (ASX:RAD), a developer of a world...
Summary CVS Health Corporation reported FY22 earnings this week. The company grew revenues by >10% and on an adjusted basis at least, EPS grew slightly. Performance across all 3 business segments - healthcare benefits, retail, and pharmacy benefits - was solid and the outlook for 202...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes trading in ...
Are These Penny Stocks In For A Short Squeeze? Penny stocks are shares of companies that trade for less than $5 per share. They also tend to represent smaller companies. Their higher risk/higher reward makeup generally makes them a hot topic for retail traders. Any given day might see low-pri...
Summary Rite Aid Corporation is a name that is very familiar to arbitrageurs because of its history of failed mergers. Rite Aid recently announced that Heyward Donigan, the company’s President and Chief Executive Officer, had stepped down, effective immediately. Elizabeth ("B...
Rite Aid ( NYSE: RAD ) rose 6% amid takeover speculation after the company announced CEO Heyward Donigan has left the company was was replaced by an interim CEO. Elizabeth Burr is taking over as CEO at the drugstore chain, according to a statement. Donigan's departure after th...
Healthcare industry expert Elizabeth Burr has been elected as interim CEO at U.S. drugstore chain Rite Aid ( NYSE: RAD ), effective immediately. Burr, a member of the company’s board, will succeed president and CEO Heyward Donigan, who has left the company. She has extensiv...
Heyward Donigan Departs from the Company as President and CEO C ompany Reaffirms Fiscal 2023 Financial Guidance Rite Aid Corporation (NYSE: RAD) (“Rite Aid” or the “Company”) announced today that its Board of Directors has appointed Elizabeth (...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes trading in ...
News, Short Squeeze, Breakout and More Instantly...
Secures Interim Approval to Access Up to $3.45 Billion in Debtor-in-Possession Financing Continues to Serve Customers and Deliver Healthcare Products and Services Across Retail and Online Platforms Rite Aid Corporation (OTC: RADCQ) (“Rite Aid” or the “Compan...
Stein Succeeds Elizabeth “Busy” Burr Rite Aid Corporation (NYSE: RAD) (“Rite Aid” or the “Company”) today announced that its Board of Directors has appointed Jeffrey S. Stein as Chief Executive Officer (CEO), Chief Restructuring Officer (CRO) an...
Reaches Agreement in Principle with Key Creditors on the Terms of Financial Restructuring Plan Initiates Voluntary Chapter 11 Process to Implement a Consensual Financial Restructuring That Will Significantly Reduce Debt and Enable Execution of Key Initiatives Receives Commitment f...